TCRCure Biopharma
PrivateLast Round
Series B
Feb 16, 2022
Total Funding Raised
$47.3M
Company Overview
TCRCure is a biotechnology company specializing in the development of cancer immunotherapies through advanced techniques such as high throughput antigen-specific TCR cloning, large-scale virus production, T cell genetic engineering, and immune cell manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TCRCure Biopharma Comparables
Compare TCRCure Biopharma with similar companies based on industry and business-model similarity.
TCRCure Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 16, 2022 | ||||
| Series B | Dec 28, 2018 | ||||
| Series A | Apr 1, 2018 |
TCRCure Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B |
| CCB Financial Assets Investment | Series B |
| 德同资本 | Series B |
| Share Capital | Series B |
| Founder Hesheng Investment Co., Ltd. | Series B |
TCRCure Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TCRCure Biopharma's valuation, stock price, and market status.
Is TCRCure Biopharma a public or private company?
TCRCure Biopharma is a private company.
What is the current stock price of TCRCure Biopharma?
TCRCure Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is TCRCure Biopharma worth (valuation)?
Valuation information for TCRCure Biopharma is not publicly available.
Can I buy TCRCure Biopharma stock?
TCRCure Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TCRCure Biopharma's last funding round?
TCRCure Biopharma's most recent funding round was Series B on February 16, 2022.
Who are the main investors in TCRCure Biopharma?
Key investors in TCRCure Biopharma include CCB Financial Assets Investment.
Will TCRCure Biopharma IPO soon?
No public IPO plans have been announced for TCRCure Biopharma.
How can I track TCRCure Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TCRCure Biopharma's secondary market activity and sign up for updates.